adult product Recalls

989 recalls tagged with “adult product”.

Health & Personal Care
HIGH
FDA DRUG

Sun Pharmaceutical Radiopharmaceutical Kit Recall: 1,870 Kits Recalled for OOS Dissolution Issue

Sun Pharmaceutical Industries recalled 1,870 kits nationwide after an out-of-specification dissolution test for sulphate in Sodium Tartrate Dihydrate used to produce Mertiatide. The recall affects Rx-only kits distributed across the U.S. Healthcare providers and patients should stop using the product immediately and follow guidance from Sun Pharmaceutical. Contact information is provided by the UQ

Sun Pharmaceutical Industries
Failed Dissolution
Read more
Health & Personal Care
HIGH
FDA DRUG

Zydus Lifesciences Chlorpromazine Hydrochloride 100 mg Recall 2025

Zydus Lifesciences Ltd. and Zydus Pharmaceuticals (USA) Inc. recall Chlorpromazine Hydrochloride Tablets, USP, 100 mg, 100-count bottles distributed nationwide in the United States. The recall stems from CGMP deviations that allowed N-Nitroso Desmethyl Chlorpromazine to exceed the acceptable intake limit. Health care providers and patients should stop using the product and contact the manufacturer

Zydus Lifesciences
CGMP Deviations:
Read more
Health & Personal Care
HIGH
FDA DEVICE

PHILIPS Allura Xper FD10/10 Recall Tied to BIOS Battery Depletion

Philips Medical Systems Nederland B.V. recalled 585 units of the Allura Xper FD10/10 diagnostic system globally, including 145 in the United States, after reports that the BIOS battery can deplete faster than expected and halt system startup. The recall covers models 722005, 722011, and 722027. Healthcare facilities should stop using the device and follow manufacturer instructions for remediation.

Philips Medical Systems Nederland B.V.
The BIOS
Read more
Health & Personal Care
HIGH
FDA DEVICE

Philips Allura Xper FD20 BiOS Battery Recall Affects 5,067 Units Worldwide

Philips Medical Systems Nederland B.V. recalls 5,067 Allura Xper FD20 imaging systems worldwide. The BIOS battery may deplete faster than planned, causing the system to fail to start. The issue affects 1,626 US and 3,441 international units. Customers should stop using affected devices and follow manufacturer instructions.

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
The BIOS
Read more
Health & Personal Care
HIGH
FDA DEVICE

Philips Allura Xper FD10 Recalled for BIOS Battery Startup Failure (2,317 Units Worldwide, 2025)

Philips Medical Systems Nederland recalled 2,317 Allura Xper FD10 imaging systems worldwide, including 497 in the United States. The BIOS battery may deplete faster than expected, causing the startup process to halt with no user alerts. Hospitals should stop using the devices and await manufacturer instructions.

Philips Medical Systems Nederland
The BIOS
Read more
Health & Personal Care
HIGH
FDA DEVICE

Philips Recalling 298 Allura Xper FD20 OR Tables Worldwide Over BIOS Battery Risk (2025)

Philips Medical Systems Nederland B.V. recalled 298 Allura Xper FD20 OR Tables worldwide after a BIOS battery depletion risk could prevent the system from starting. The battery may run down faster than designed, halting startup with no warning. Hospitals and clinicians should stop using the devices immediately and await recall instructions by letter.

Philips
The BIOS
Read more
Health & Personal Care
HIGH
FDA DEVICE

Philips Medical Systems Nederland Recall Expands for Allura Xper FD20/15 OR Table Model 722059 (2025

Philips Medical Systems Nederland B.V. recalls 8 medical tables worldwide due to BIOS battery depletion risk. The recall affects Allura Xper FD20/15 OR Tables with model number 722059. The BIOS battery may deplete faster than expected, causing the system not to start without warning. Hospitals and healthcare providers should stop using the device immediately and follow the recall instructions.

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
The BIOS
Read more
Health & Personal Care
HIGH
FDA DEVICE

Philips Medical Systems Nederland Recall: BIOS Battery Causes Startup Failures in Allura Xper CV20 7

Philips Medical Systems Nederland B.V. recalls 53 units of the Allura Xper CV20 system due to a BIOS battery that may deplete faster than designed. The recall affects units distributed worldwide, including the US and many other countries. The failure prevents system startup with no prior warning messages.

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
The BIOS
Read more
Health & Personal Care
HIGH
FDA DRUG

Viorele Desogestrel/Ethinyl Estradiol Recall 2025 for Impurities

Viorele birth-control pills are recalled in the United States for failed impurity and degradation specifications. Glenmark Pharmaceuticals Inc. is distributing the issue nationwide, affecting 26,928 packs. Patients should stop using the product and contact a clinician for guidance.

Viorele
Failed Impurities/Degradation
Read more
Health & Personal Care
HIGH
FDA DEVICE

Philips Medical Systems Nederland Blames BIOS Battery Design Flaw in Allura Centron 722400 Recall (Z

Philips Medical Systems Nederland B.V. recalls 313 Allura Centron devices with model 722400 worldwide after a BIOS battery drains too quickly. The issue can halt the system start-up with no user warning. The recall was issued September 3, 2025 and remains active as of October 8, 2025. Consumers should contact Philips or their healthcare provider for instructions.

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
The BIOS
Read more
Health & Personal Care
HIGH
FDA DEVICE

Philips Medical Systems FD20 Biplane OR Table Recall for BIOS Battery Depletion (2025)

Philips Medical Systems Nederland B.V. recalls Allura Xper FD20 Biplane OR Table models 722020 and 722025. Four units are affected worldwide, including two in the United States. The BIOS battery may deplete faster than expected, halting the system startup with no user warning. The recall advises stop-use and coordination with healthcare providers for instructions.

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
The BIOS
Read more
Health & Personal Care
HIGH
FDA DEVICE

Inpeco Recall: 8 FlexLab FLX Potassium Test System Units Over Unverified HIL Function (2025)

Inpeco recalled eight FlexLab FLX System Potassium Test System units sold in California and New York. The recall targets the Sample Integrity Module HIL function, which detects hemolysis, icterus and lipemia. The FDA has not evaluated this function for safety or effectiveness, risking erroneous results or delays. Labs should stop using the device immediately.

Inpeco
The FlexLab
Read more
Health & Personal Care
HIGH
FDA DEVICE

Philips Medical Systems Nederland Faces High-Risk Recall for Allura Xper FD20/15 BIOS Battery

Philips Medical Systems Nederland B.V. recalls 300 units of the Allura Xper FD20/15 with model 722058 after the BIOS battery may deplete prematurely, causing startup failure. The recall covers worldwide distribution. Patients and healthcare providers should stop using the device immediately and follow manufacturer instructions.

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
The BIOS
Read more
Food & Beverages
HIGH
FDA FOOD

New Spirit Naturals Ultra Whey Protein Powder Recalled for Undeclared Milk Allergen

New Spirit Naturals recalled 37 units of Ultra Whey Protein Powder sold directly through its online store after undeclared milk allergen was detected. The recall is currently active with a high-hazard designation. Consumers who have purchased the product should not consume it and should contact the company for refunds or replacements.

New Spirit Naturals
undeclared allergen
Read more
Health & Personal Care
HIGH
FDA DRUG

Major Pharmaceuticals Sulfamethoxazole and Trimethoprim 800 mg/160 mg 100-Tablets Recall 2025

Major Pharmaceuticals recalls sulfamethoxazole and trimethoprim 800 mg/160 mg double-strength tablets sold nationwide. A specific lot of packaging coil used in production was found to contain a microorganism in the packaging area, though no microorganism was detected on the tablets. Consumers should stop using the product and follow guidance from Major Pharmaceuticals or their healthcare provider.

Sulfamethoxazole and Trimethoprim
Presence of
Read more
Health & Personal Care
HIGH
FDA DRUG

High-Risk Antibiotic Recall: Sulfamethoxazole and Trimethoprim 800/160 mg Double Strength Packets Re

A high-risk recall of sulfamethoxazole and trimethoprim 800 mg/160 mg double-strength tablets is active nationwide in the United States. The Harvard Drug Group and distribution partners have halted use of a lot due to a foreign-substance finding in packaging material. No tablets tested positive for micro-organisms. Consumers should stop using the product and consult their healthcare providers.

SULFAMETHOXAZOLE AND TRIMETHOPRIM
Presence of
Read more